Project selected for Fund for Translational Biomedical Research
The project ‘Efficacy of defined bacteriotherapy in treatment of Ulcerative Colitis’ has been selected for the Fund for Translational Biomedical Research. The research team includes prof. Séverine Vermeire, department of Clinical and Experimental Medicine, and prof. Jeroen Raes, department of Microbiology and Immunology. For three years, the project will receive an annual budget of € 80.000 to study clinical applications of basic research findings.
The Biomedical Sciences Group has created a Fund for Translational Biomedical Research (FTBO). Aim of the fund is to provide an annual credit for the coming ten years. It will support clinicians and basic researchers so that they can further study the clinical applications of their basic research findings.
21 project applications
This year, 21 high-quality project applications were submitted. An advisory council assessed the projects. The council was led by the research coordinator of the Biomedical Sciences Group and includes the chairman, a member of the clinical research and education council (KOOR) and three department chairs.
1 selected project
On the advice of the council, the Executive Committee selected one project that will receive an annual budget of € 80.000 the coming three years – i.e. a total of € 240.000: Efficacy of defined bacteriotherapy in treatment of Ulcerative Colitis. The research team includes prof. Jeroen Raes and prof. Séverine Vermeire.
New call in 2017
The Executive Committee wants to wish the researchers the best of luck in the execution of their project. In addition, the Executive Committee wishes to thank all other researchers for their interesting project applications and would like to point out that next year there will be a similar call for project applications.